↓ Skip to main content

PLOS

Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050

Overview of attention for article published in PLOS ONE, February 2012
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
8 X users

Citations

dimensions_citation
142 Dimensions

Readers on

mendeley
277 Mendeley
Title
Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050
Published in
PLOS ONE, February 2012
DOI 10.1371/journal.pone.0030216
Pubmed ID
Authors

Reuben Granich, James G. Kahn, Rod Bennett, Charles B. Holmes, Navneet Garg, Celicia Serenata, Miriam Lewis Sabin, Carla Makhlouf-Obermeyer, Christina De Filippo Mack, Phoebe Williams, Louisa Jones, Caoimhe Smyth, Kerry A. Kutch, Lo Ying-Ru, Marco Vitoria, Yves Souteyrand, Siobhan Crowley, Eline L. Korenromp, Brian G. Williams

Abstract

Antiretroviral Treatment (ART) significantly reduces HIV transmission. We conducted a cost-effectiveness analysis of the impact of expanded ART in South Africa.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 277 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 4 1%
South Africa 4 1%
Mozambique 1 <1%
Switzerland 1 <1%
Kenya 1 <1%
Unknown 266 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 71 26%
Researcher 48 17%
Student > Ph. D. Student 32 12%
Student > Postgraduate 21 8%
Student > Bachelor 17 6%
Other 47 17%
Unknown 41 15%
Readers by discipline Count As %
Medicine and Dentistry 78 28%
Social Sciences 25 9%
Economics, Econometrics and Finance 22 8%
Nursing and Health Professions 18 6%
Agricultural and Biological Sciences 18 6%
Other 54 19%
Unknown 62 22%